Limited coverage drugs – ticlopidine
Last updated on October 25, 2022
| Generic name | ticlopidine |
| Strength | 250 mg |
| Form | tablet |
|
Special Authority criteria |
Approval period |
|---|---|
|
For use in secondary prevention of coronary, cerebral and peripheral vascular occlusion and embolization where patient has experienced failure on or intolerance to ASA. |
Indefinite |
Practitioner exemptions
- None
Special notes
- None